Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and Infections, Serratia

carbapenems has been researched along with Infections, Serratia in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's5 (26.32)29.6817
2010's11 (57.89)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Botha, A; Brink, AJ; Copelyn, J; Eley, B; Tootla, HD1
Chu, W; Huang, L; Jia, J; Sheng, Y; Xu, A; Xu, H; Zhang, L1
Hardwick, SW; Luisi, BF; Salmond, GPC; Tichy, EM1
Caio, C; Conaldi, PG; Cuscino, N; Di Mento, G; Fontana, I; Gona, F; Iannolo, G; Maugeri, G; Mezzatesta, ML; Monaco, F; Panarello, G; Stefani, S1
Taylor, B; Taylor, SP1
Boyd, D; Bryce, E; Embree, J; Fuller, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Langley, J; Mataseje, L; Mitchell, R; Mulvey, M; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N1
Dortet, L; Jeannot, K; Naas, T; Nordmann, P; Oueslati, S; Tandé, D1
Carvalhaes, CG; Cayô, R; Croda, J; Gales, AC; Patussi Correia Sacchi, F; Ramos da Silva, AC; Rodrigues-Costa, F; Silva, KE; Simionatto, S1
Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY1
Hu, Q; Hu, Y; Lin, X; Lv, H; Xu, X; Zhang, R1
Ahmed, AM; Hara, T; Ikeda, M; Kayama, S; Khalifa, HO; Kuroo, Y; Shimamoto, T; Soliman, AM; Sugai, M1
Kimouli, M; Kosmopoulou, O; Petropoulou, D; Poulou, A; Pournaras, S; Ranellou, K; Tsakris, A; Voulgari, E1
Chudyk, EI; Correia, A; Fonseca, F; Mulholland, AJ; Spencer, J; van der Kamp, MW1
Endo, M; Gondaira, F; Hatakeyama, K; Iwakura, N; Iwaya, A; Kurihara, M; Kuwano, T; Nakagawa, S; Taneike, I; Yamamoto, T1
Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL1
Bush, K; Lolans, K; Queenan, AM; Quinn, J; Schreckenberger, P; Shang, W1
Bernabeu, S; Bille, J; Naas, T; Nordmann, P; Poirel, L; Wenger, A1
Carrër, A; Church, D; Nordmann, P; Pitout, JD; Poirel, L1
Nakamura, J; Soejima, R1

Reviews

2 review(s) available for carbapenems and Infections, Serratia

ArticleYear
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome

2016
[Serratia marcescens pneumonia].
    Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1

    Topics: Carbapenems; Diagnosis, Differential; Humans; Immunocompromised Host; Pneumonia, Bacterial; Prognosis; Serratia Infections; Serratia marcescens

1999

Other Studies

17 other study(ies) available for carbapenems and Infections, Serratia

ArticleYear
Using ceftazidime-avibactam for persistent carbapenem-resistant Serratia marcescens infection highlights antimicrobial stewardship challenges with new beta-lactam-inhibitor combination antibiotics.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2021, Aug-02, Volume: 111, Issue:8

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Azabicyclo Compounds; Burns; Carbapenems; Ceftazidime; Drug Combinations; Female; Humans; Infant; Serratia Infections; Serratia marcescens; South Africa

2021
Genomic characterization of two carbapenem-resistant
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Serratia Infections; Serratia marcescens

2023
1.8 Å resolution crystal structure of the carbapenem intrinsic resistance protein CarF.
    Acta crystallographica. Section D, Structural biology, 2017, Jul-01, Volume: 73, Issue:Pt 7

    Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Crystallography, X-Ray; Humans; Models, Molecular; Protein Conformation; Serratia; Serratia Infections

2017
Detection of the IncX3 plasmid carrying blaKPC-3 in a Serratia marcescens strain isolated from a kidney-liver transplanted patient.
    Journal of medical microbiology, 2017, Volume: 66, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Humans; Kidney Transplantation; Liver Transplantation; Plasmids; Serratia Infections; Serratia marcescens

2017
Pseudohemoptysis due to Serratia marcescens.
    Journal of general internal medicine, 2014, Volume: 29, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Diagnosis, Differential; Doripenem; Hemoptysis; Humans; Male; Serratia Infections; Serratia marcescens; Sputum; Treatment Outcome

2014
Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:3

    Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Endodeoxyribonucleases; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Hospitals; Humans; Interspersed Repetitive Sequences; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Plasmids; Replicon; Sequence Alignment; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens

2015
Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens

2015
Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
    Journal of clinical microbiology, 2015, Volume: 53, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Female; Genes, Bacterial; Hospitals, Teaching; Humans; Infant; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens; Tigecycline

2015
Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    The Journal of hospital infection, 2016, Volume: 94, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; China; DNA, Bacterial; Ertapenem; Female; Genotype; Hospitals; Humans; Hydrolysis; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult

2016
High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Morganella morganii; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens

2017
In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:7

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Pneumonia, Bacterial; Serratia Infections; Serratia marcescens

2010
The basis for carbapenem hydrolysis by class A β-lactamases: a combined investigation using crystallography and simulations.
    Journal of the American Chemical Society, 2012, Nov-07, Volume: 134, Issue:44

    Topics: beta-Lactamases; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Hydrolysis; Molecular Dynamics Simulation; Point Mutation; Serratia; Serratia Infections

2012
Rapid and quantitative detection of blood Serratia marcescens by a real-time PCR assay: its clinical application and evaluation in a mouse infection model.
    FEMS microbiology letters, 2005, Jul-15, Volume: 248, Issue:2

    Topics: Animals; Carbapenems; Disease Models, Animal; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Sensitivity and Specificity; Sepsis; Serratia Infections; Serratia marcescens

2005
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan

2006
SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Middle Aged; Serratia Infections; Serratia marcescens

2006
SME-2-producing Serratia marcescens isolate from Switzerland.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Middle Aged; Serratia Infections; Serratia marcescens; Switzerland

2007
Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Drug Resistance, Microbial; Humans; Serratia Infections; Serratia marcescens

2008